Capital Market Strategies’s CVS Health CVS Stock Holding History

Capital Market Strategies’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,702	Closed	-$216K	–	153
2024 Q1	$216K	Hold	2,702	–	–	0.16%	132
2023 Q4	$213K	Sell	2,702 -366	-12%	-$26K	0.19%	132
2023 Q3	$212K	Sell	3,068 -132	-4%	-$9.35K	0.21%	125
2023 Q2	$221K	Buy	+3,200	New	+$228K	0.2%	123
2023 Q1	–	Sell	-3,317	Closed	-$309K	–	58
2022 Q4	$309K	Buy	3,317 +96	+3%	+$9.26K	0.33%	82
2022 Q3	$307K	Buy	3,221 +44	+1%	+$4.36K	0.35%	83
2022 Q2	$294K	Buy	3,177 +600	+23%	+$58.6K	0.31%	94
2022 Q1	$261K	Hold	2,577	–	–	0.23%	121
2021 Q4	$266K	Buy	+2,577	New	+$238K	0.22%	116

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Capital Market Strategies's CVS Position: Q2 2024 in Review

Capital Market Strategies sold out of CVS Health (CVS) in Q2 2024, closing a stake of 2,702 shares — an estimated $216K sold.

Capital Market Strategies first reported a position in CVS in Q4 2021 and held it in 9 quarters. The position peaked at $309K in Q4 2022. 1,914 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

Capital Market Strategies reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
Capital Market Strategies sold 2,702 CVS Health shares in Q2 2024, an estimated $216K.
Capital Market Strategies first reported a position in CVS Health in Q4 2021 and held it in 9 quarters.
Capital Market Strategies's CVS Health position peaked at $309K in Q4 2022.
1,914 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Capital Market Strategies's 13F filing for Q2 2024, filed 1 Jul 2024.